UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma

Clinical cancer research, 2015-01, Vol.21 (1), p.175-183

2015

Volltextzugriff (PDF)

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas

Oncotarget, 2016-09, Vol.7 (37), p.59209-59219

2016

Volltextzugriff (PDF)

Identification of a Novel Amplicon at 1q31 in Pancreatic Cancer Cell Lines

Cancer genetics and cytogenetics, 1999-09, Vol.113 (2), p.110-114

1999

Volltextzugriff (PDF)

The Philadelphia Chromosome as a Secondary Change in Leukemia: Three Case Reports and an Overview of the Literature

Cancer genetics and cytogenetics, 1998-03, Vol.101 (2), p.148-151

1998

Volltextzugriff (PDF)

Some observations on fluorescence in situ hybridization evaluation of chronic myelocytic leukemia

Cancer genetics and cytogenetics, 1997-10, Vol.98 (1), p.1-3

1997

Volltextzugriff (PDF)

Appreciation of the significance of cytogenetic and FISH analysis of bone marrow in clinical oncology

Cancer genetics and cytogenetics, 1994-11, Vol.78 (1), p.10-14

1994

Volltextzugriff (PDF)

Identification of complex t(15;17) in APL by FISH

Cancer genetics and cytogenetics, 1994, Vol.72 (1), p.73-74

1994

Volltextzugriff (PDF)

FISH: A useful technique in the verification of clonality of random chromosome abnormalities

Cancer genetics and cytogenetics, 1993-03, Vol.66 (1), p.73-74

1993

Volltextzugriff (PDF)

Trisomy 10: Age and leukemic lineage associations

Cancer genetics and cytogenetics, 1996-07, Vol.89 (2), p.173-174

1996

Volltextzugriff (PDF)

FISH in the evaluation of pleural and ascitic fluids

Cancer genetics and cytogenetics, 1995-10, Vol.84 (2), p.116-119

1995

Volltextzugriff (PDF)

Involvement of 10q22 and 11q13 in hibernoma

Cancer genetics and cytogenetics, 1994, Vol.72 (1), p.59-64

1994

Volltextzugriff (PDF)

Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes

Cancer genetics and cytogenetics, 1993-10, Vol.70 (2), p.103-107

1993

Volltextzugriff (PDF)

A case of therapy-related extramedullary acute promyelocytic leukemia

Cancer genetics and cytogenetics, 1996, Vol.86 (1), p.29-30

1996

Volltextzugriff (PDF)

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL

Cancer genetics and cytogenetics, 1992-09, Vol.62 (2), p.130-133

1992

Volltextzugriff (PDF)

Spontaneous expression of the chromosome fragile site at 10q23 in leiomyoma

Cancer genetics and cytogenetics, 1994-05, Vol.74 (1), p.73-75

1994

Volltextzugriff (PDF)

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

The New England journal of medicine, 2018-12, Vol.379 (26), p.2517-2528

2018

Volltextzugriff (PDF)

Mammographic Density Phenotypes and Risk of Breast Cancer: A Meta-analysis

JNCI : Journal of the National Cancer Institute, 2014-05, Vol.106 (5), p.1

2014

Volltextzugriff (PDF)

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

Leukemia, 2018-12, Vol.32 (12), p.2546-2557

2018

Volltextzugriff (PDF)

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2429-2440

2002

Volltextzugriff (PDF)

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

BMC cancer, 2017-12, Vol.17 (1), p.852-852, Article 852

2017

Volltextzugriff (PDF)

Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia

The New England journal of medicine, 2023-12, Vol.389 (26), p.2446-2456

2023

Volltextzugriff (PDF)

Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds

Breast cancer research : BCR, 2018-12, Vol.20 (1), p.152-152, Article 152

2018

Volltextzugriff (PDF)

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

Leukemia, 2021-10, Vol.35 (10), p.2854-2861

2021

Volltextzugriff (PDF)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

The lancet oncology, 2019-06, Vol.20 (6), p.781-794

2019

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Humans
(50)
Female
(43)
Aged
(28)
Biological And Medical Sciences
(26)
Middle Aged
(26)
Medical Sciences
(25)
Male
(23)
Adult
(18)
Risk Factors
(17)
Mammography
(15)
Genetics & Heredity
(14)
Tumors
(13)
Breast Cancer
(12)
Case-Control Studies
(11)
Aged, 80 And Over
(10)
Body Mass Index
(10)
Breast Neoplasms - Diagnostic Imaging
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas

Identification of a Novel Amplicon at 1q31 in Pancreatic Cancer Cell Lines

The Philadelphia Chromosome as a Secondary Change in Leukemia: Three Case Reports and an Overview of the Literature

Some observations on fluorescence in situ hybridization evaluation of chronic myelocytic leukemia

Appreciation of the significance of cytogenetic and FISH analysis of bone marrow in clinical oncology

Identification of complex t(15;17) in APL by FISH

FISH: A useful technique in the verification of clonality of random chromosome abnormalities

Trisomy 10: Age and leukemic lineage associations

FISH in the evaluation of pleural and ascitic fluids

Involvement of 10q22 and 11q13 in hibernoma

Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes

A case of therapy-related extramedullary acute promyelocytic leukemia

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL

Spontaneous expression of the chromosome fragile site at 10q23 in leiomyoma

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Mammographic Density Phenotypes and Risk of Breast Cancer: A Meta-analysis

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk

Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia

Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Aktive Filter

Suchergebnisse filtern